Literature DB >> 20685029

Expression of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinase-1 (TIMP-1, TIMP-2 and TIMP-3) in women with uterine prolapse but without urinary incontinence.

Ching-Chung Liang1, Hong-Yuan Huang, Ling-Hong Tseng, Shuenn-Dhy Chang, Tsia-Shu Lo, Chyi-Long Lee.   

Abstract

OBJECTIVE: To investigate the activities of matrix metalloproteinase-2 (MMP-2) and its inhibitors, tissue inhibitor of metalloproteinase-1, -2 and -3 (TIMP-1, TIMP-2 and TIMP-3), in the pelvic support and nonsupport tissue of women with uterine prolapse but without urinary incontinence. STUDY
DESIGN: Paired samples of uterosacral ligament and cervical tissue were obtained from 11 postmenopausal and 8 premenopausal women with severe uterine prolapse. Nine premenopausal women without prolapse were selected as normal controls. Immunoreactivity of MMP-2 and TIMPs was demonstrated by immunohistochemistry. Steady state of MMP-2 as well as TIMPs messenger RNA (mRNA) expression was analyzed by polymerase chain reaction (PCR) with quantitative expression determined by multiplex PCR.
RESULTS: A significantly higher expression of MMP-2 mRNA and lower expression of TIMP-2 mRNA were found in uterosacral ligament in uterine prolapse women compared to controls. In the cervical tissue, however, the MMP-2 and TIMPs mRNA expression was comparable between prolapse and control groups. With regard to menopausal status, there was no significant difference in MMP-2 and TIMPs mRNA expression between premenopausal and postmenopausal women with uterine prolapse.
CONCLUSIONS: An increase in MMP-2 mRNA and a decrease in TIMP-2 mRNA expression in uterosacral ligament are related to uterine prolapse in women without urinary incontinence.
Copyright © 2010. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685029     DOI: 10.1016/j.ejogrb.2010.06.008

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Immunolocalization of Advanced Glycation End Products, Mitogen Activated Protein Kinases, and Transforming Growth Factor-β/Smads in Pelvic Organ Prolapse.

Authors:  Antonella Vetuschi; Simona Pompili; Anna Gallone; Angela D'Alfonso; Maria Gabriella Carbone; Gaspare Carta; Claudio Festuccia; Eugenio Gaudio; Alessandro Colapietro; Roberta Sferra
Journal:  J Histochem Cytochem       Date:  2018-05-08       Impact factor: 2.479

Review 2.  Anterior pelvic organ prolapse repair using synthetic mesh.

Authors:  Bhavin N Patel; Alvaro Lucioni; Kathleen C Kobashi
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

3.  Transforming growth factor β1 and extracellular matrix protease expression in the uterosacral ligaments of patients with and without pelvic organ prolapse.

Authors:  Ava Leegant; Lisa C Zuckerwise; Keith Downing; Jurriaan Brouwer-Visser; Changcheng Zhu; Maria Jose Cossio; Felix Strube; Xianhong Xie; Erika Banks; Gloria S Huang
Journal:  Female Pelvic Med Reconstr Surg       Date:  2015 Jan-Feb       Impact factor: 2.091

4.  The role of GPX1 in the pathogenesis of female pelvic organ prolapse.

Authors:  Shasha Hong; Li Hong; Bingshu Li; Debin Wu; Cheng Liu; Jie Min; Wenjun Guo; Ming Hu; Jianming Tang; Yang Li
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

5.  Fibroblasts from women with pelvic organ prolapse show differential mechanoresponses depending on surface substrates.

Authors:  Alejandra M Ruiz-Zapata; Manon H Kerkhof; Behrouz Zandieh-Doulabi; Hans A M Brölmann; Theo H Smit; Marco N Helder
Journal:  Int Urogynecol J       Date:  2013-04-12       Impact factor: 2.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.